Canada Pension Plan Investment Board
KRTX

Canada Pension Plan Investment Board’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,900
Closed -$527K – 1124
2023
Q1 		$527K Sell
2,900
-16,100
-85% -$3.08M ﹤0.01% 959
2022
Q4 		$3.73M Buy
+19,000
New +$4.07M 0.01% 585

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board's KRTX Position: Q2 2023 in Review

Canada Pension Plan Investment Board sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 2,900 shares — an estimated $527K sold.

Canada Pension Plan Investment Board first reported a position in KRTX in Q4 2022 and held it in 2 quarters. The position peaked at $3.73M in Q4 2022. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

  • Canada Pension Plan Investment Board reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 2,900 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $527K.
  • Canada Pension Plan Investment Board first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Karuna Therapeutics, Inc. Common Stock position peaked at $3.73M in Q4 2022.
  • 289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2023, filed 9 Aug 2023.